Association of interleukin-18 promoter polymorphism and atherosclerotic diseases in Chinese patients with diabetic nephropathy

Nephrology

Volumn 14, Issue 6, 2009, Pages 606-612

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Poon, Peter Yam Kau ^a   Kwan, Bonnie Ching Ha ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiovascular disease; Genetics; Renal failure

Indexed keywords

INTERLEUKIN 18;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETIC NEPHROPATHIES; FEMALE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 69449108210     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01075.x     Document Type: Article

References (39)

1. Ho YW, Chau KF, Leung CB et al. Kong registry report 2004. Hong Kong J. Nephrol. 2005 7 : 38 46.
2. Constatini E. United States renal data system 2006 annual data report. Am. J. Kidney Dis. 2007 49 (Suppl 1 s1 296.
3. Szeto CC, Wong TY, Leung CB et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int. 2000 58 : 400 407.
4. Weiner DE, Tabatabai S, Tighiouart H et al. Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease. Am. J. Kidney Dis. 2006 48 : 392 401.
5. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin. Dial. 2003 16 : 101 105. (Pubitemid 37361072)
6. Reddy P. Interleukin-18: Recent advances. Curr. Opin. Hematol. 2004 11 : 405 410.
7. Mahmoud RA, el-Ezz SA, Hegazy AS. Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Ital J. Biochem. 2004 53 : 73 81.
8. Bosch M, Lopez-Bermejo A, Vendrell J, Musri M, Ricart W, Fernandez-Real JM. Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass. Diabetologia 2005 48 : 1841 1843.
9. Zhang YF, Yang YS, Hong J et al. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 2006 29 : 419 423.
10. Nakamura A, Shikata K, Hiramatsu M et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005 28 : 2890 2895.
11. Blankenberg S, Tiret L, Bickel C et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002 106 : 24 30.
12. Skurk T, Kolb H, Müller-Scholze S, Röhrig K, Hauner H, Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur. J. Endocrinol. 2005 152 : 863 868.
13. Kretowski A, Kinalska I. Serum levels of interleukin-18 - A potential marker of cardiovascular death - could be determined by genetic predisposition. Circulation 2003 107 : e206 207.
14. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J. Neuroimmunol. 2001 112 : 146 152.
15. Liang XH, Cheung W, Heng CK, Wang DY. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem. Biophys. Res. Commun. 2005 338 : 736 741.
16. Arimitsu J, Hirano T, Higa S et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem. Biophys. Res. Commun. 2006 342 : 1413 1416.
17. Dong GP, Yu ZS, Liang L, Zou CC, Fu JF, Wang CL. IL-18 gene promoter-137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus. Int. J. Immunogenet. 2007 34 : 75 9.
18. Hernesniemi JA, Karhunen PJ, Rontu R et al. Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: The Helsinki Sudden Death Study. Atherosclerosis 2008 196 : 643 649.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987 40 : 373 383.
20. Wong TY, Poon P, Szeto CC, Chan JC, Li PK. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int. 2000 57 : 632 638.
21. Wong TY, Szeto CC, Chow KM, Chan JC, Li PK. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy. Am. J. Kidney Dis. 2001 38 : 9 17.
22. Szeto CC, Chow KM, Poon PY, Kwan BC, Li PK. Peroxisome proliferator-activated receptor-gamma gene polymorphism and the risk of cardiovascular disease in patients with diabetic nephropathy. Am. J. Nephrol. 2008 28 : 715 722.
23. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006 17 : 2937 2944.
24. Takada T, Suzuki E, Morohashi K, Gejyo F. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 2002 60 : 36 42.
25. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol. Dial. Transplant. 2003 18 : 977 982.
26. Goraya TY, Jacobsen SJ, Belau PG, Weston SA, Kottke TE, Roger VL. Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota. Mayo Clin. Proc. 2000 75 : 681 687.
27. Cox D. Regression models and life-tables. J. R. Stat. Soc. 1972 34 : 187 201.
28. Balakrishnan VS, Guo D, Rao M et al. Cytokine gene polymorphisms in hemodialysis patients: Association with comorbidity, functionality, and serum albumin. Kidney Int. 2004 65 : 1449 1460.
29. Rao M, Guo D, Jaber BL et al. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int. 2004 66 : 419 427.
30. Buraczynska M, Mierzicki P, Buraczynska K, Dragan M, Ksiazek A. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol. Diagn. Ther. 2007 11 : 257 263.
31. Losito A, Kalidas K, Santoni S, Errico R, Jeffery S. Association of the -159C/T polymorphism of the endotoxin receptor (CD14) with carotid artery disease and cardiovascular mortality in dialysis patients. Blood Purif. 2005 23 : 128 133.
32. Menon V, Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int. 2005 68 : 1413 1418.
33. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Int. 2006 70 : 26 33.
34. Kovesdy CP, Anderson JE. Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis. Semin. Dial. 2007 20 : 566 569.
35. Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA. Reverse epidemiology: A confusing, confounding, and inaccurate term. Semin. Dial. 2007 20 : 586 592.
36. Kaysen GA. Association between inflammation and malnutrition as risk factors of cardiovascular disease. Blood Purif. 2006 24 : 51 5.
37. Girndt M, Stenvinkel P, Ulrich C et al. Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients. Nephrol. Dial. Transplant. 2007 22 : 3586 3592.
38. Sharples EJ, Varagunam M, Sinnott PJ, McCloskey DJ, Raftery MJ, Yaqoob MM. The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 2006 26 : 64 8.
39. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann. Intern. Med. 1999 130 : 461 470.